Pancreatic Cancer Research

ResearcherMaastricht UniversityActive in the last 2 years

Ruth A.L. Willems

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5157-0191; OpenAlex author ID A5112644126. Sources: OpenAlex.

Their work

Papers
8 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
20
Papers, trials and grants by year

2023: 1 paper · 2024: 2 papers · 2025: 1 paper · 2026: 4 papers

Papers 8

  1. Prevention of Venous Thromboembolism in Patients With Pancreatic Cancer: A Nationwide Survey. Co-author DOI 10.1002/cam4.72306↗
  2. Preference versus protocol: oncology clinicians' perspectives on central venous access for administration of chemotherapy in pancreatic cancer. First author DOI 10.1016/j.esmogo.2026.100311↗
  3. Plasmin Generation Kinetics Reveal a Hyperfibrinolytic Phenotype in Patients with Pancreatic Ductal Adenocarcinoma Co-author DOI 10.1055/a-2925-6824↗
  4. Thromboembolic Events During Perioperative Therapy for Resectable and Borderline Resectable Pancreatic Cancer in the PREOPANC-2 Trial. Co-author DOI 10.1200/jco-25-01935↗
  5. Delayed gastric emptying after pancreatic cancer surgery impacts time to start of adjuvant treatment but not overall survival: a post-hoc analysis of the PREOP… Last author DOI 10.1093/bjs/znaf261↗
  6. Altered whole blood thrombin generation and hyperresponsive platelets in patients with pancreatic cancer. Co-author DOI 10.1016/j.jtha.2023.12.037↗
  7. Cellular Components Contributing to the Development of Venous Thrombosis in Patients with Pancreatic Cancer. Co-author DOI 10.1055/s-0043-1777304↗
  8. Venous Thromboembolism and Primary Thromboprophylaxis in Perioperative Pancreatic Cancer Care. Co-author DOI 10.3390/cancers15143546↗

Closest collaborators

The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Judith de Vos‐Geelen · 6 shared papers, 2023–2026 · strength 1.36
  2. Hugo Ten Cate · 5 shared papers, 2023–2026 · strength 1.12
  3. Mark Roest · 4 shared papers, 2023–2026 · strength 0.86
  4. Johanna W. Wilmink · 3 shared papers, 2023–2026 · strength 0.66
  5. Merlijn U.J.E. Graus · 3 shared papers, 2023–2026 · strength 0.66
  6. Marjolein Y.V. Homs · 2 shared papers, 2026 · strength 0.50
  7. Dana Huskens · 2 shared papers, 2024–2026 · strength 0.47
  8. Nick van Es · 2 shared papers, 2023–2026 · strength 0.42
  9. Stefan A.W. Bouwense · 2 shared papers, 2023–2026 · strength 0.39
  10. Hanneke W.M. van Laarhoven · 1 shared paper, 2026 · strength 0.26
  11. Aniek E. van Diepen · 1 shared paper, 2026 · strength 0.26
  12. A.J. de Wilde · 1 shared paper, 2026 · strength 0.24
  13. Ignace H. J. T. de Hingh · 1 shared paper, 2026 · strength 0.24
  14. N C Biesma · 1 shared paper, 2026 · strength 0.24
  15. Hjalmar C. van Santvoort · 1 shared paper, 2026 · strength 0.24
  16. Elena Campello · 1 shared paper, 2024 · strength 0.23
  17. Paolo Simioni · 1 shared paper, 2024 · strength 0.23
  18. Nynke Michiels · 1 shared paper, 2023 · strength 0.15
  19. Bas Groot Koerkamp · 1 shared paper, 2023 · strength 0.15
  20. J. Sven D. Mieog · 1 shared paper, 2023 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.